Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. Belmont HM. N Engl J Med 2024;390:1245.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Belmont HM. Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. N Engl J Med 2024;390:1245.
PMID: 38598587